ABSTRACT
Intravenous immunoglobulin (IVIG) is widely used in bone marrow transplantation to modify or prevent CMV, decrease graft-versus-host disease (GvHD), prevent infections other than CMV, and treat posttransplant autoimmune disorders. Here, we review relevant data in auto-and allotransplants.
